Turn Therapeutics Inc.
$3.38
▲
7.54%
2026-04-21 09:56:01
www.turntherapeutics.com
NGM: TTRX
Explore Turn Therapeutics Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$103.07 M
Current Price
$3.38
52W High / Low
$26.5 / $2.57
Stock P/E
—
Book Value
$0.02
Dividend Yield
—
ROCE
-134.02%
ROE
-1.42%
Face Value
—
EPS
$-0.12
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
2
Beta
—
Debt / Equity
1.72
Current Ratio
0.87
Quick Ratio
1.55
Forward P/E
-22.33
Price / Sales
—
Enterprise Value
$94.79 M
EV / EBITDA
-15.04
EV / Revenue
—
Rating
None
Target Price
$8
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Hoth Therapeutics, Inc. | $0.74 | — | $13.96 M | — | -200.97% | -1.91% | $2.12 / $0.49 | $0.4 |
| 2. | Solid Biosciences Inc. | $8.49 | — | $835.34 M | — | -90.02% | -1.1% | $8.87 / $2.41 | $2.28 |
| 3. | Ovid Therapeutics Inc. | $2.89 | — | $381.12 M | — | -29.75% | -17.51% | $3.1 / $0.27 | $1 |
| 4. | Pyxis Oncology, Inc. | $1.7 | — | $104.3 M | — | -119.93% | -91.44% | $5.55 / $0.89 | $0.85 |
| 5. | ProQR Therapeutics N.V. | $1.84 | — | $206.51 M | — | -54.09% | -61.17% | $3.1 / $1.1 | $0.54 |
| 6. | IGC Pharma, Inc. | $0.32 | — | $31.52 M | — | -114.73% | -83.34% | $0.5 / $0.24 | $0.09 |
| 7. | Coeptis Therapeutics Holdings, Inc. | $15.54 | — | $91.17 M | — | -90.67% | -1.37% | $21.41 / $6.26 | $2.36 |
Quarterly Results
Figures shown in M / B
| Q3 2025 | Q2 2025 | Q3 2024 | |
|---|---|---|---|
| Sales | — | 0 M | — |
| Operating Profit | — | -1.37 M | — |
| Net Profit | — | -1.24 M | — |
| EPS in Rs | -0.06 | -0.04 | -0.02 |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | |
|---|---|---|
| Sales | 0 M | 0 M |
| Operating Profit | -1.8 M | -2.31 M |
| Net Profit | -1.77 M | -2.29 M |
| EPS in Rs | -0.06 | -0.08 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | |
|---|---|---|
| Total Assets | 2.05 M | 2.01 M |
| Total Liabilities | 2.23 M | 1.93 M |
| Equity | -0.18 M | 0.09 M |
| Current Assets | 1.1 M | 1.2 M |
| Current Liabilities | 0.71 M | 0.49 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | |
|---|---|---|
| Operating CF | -1.36 M | -1.38 M |
| Investing CF | -0.1 M | -0.04 M |
| Financing CF | 1.15 M | 0.5 M |
| Free CF | -1.46 M | -1.42 M |
| Capex | -0.1 M | -0.04 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | |
|---|---|---|
| Revenue Growth % | — | — |
| Earnings Growth % | 22.85% | — |
| Profit Margin % | — | — |
| Operating Margin % | — | — |
| Gross Margin % | — | — |
| EBITDA Margin % | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.